Wuhan Newcando Biotechnology Co.,Ltd

Myoglobin can be used as the most sensitive index in the early diagnosis of acute myocardial infarction (AMI). But the specificity is poor, skeletal muscle injury, trauma, renal failure and other diseases can lead to its rise. Although Myo positive can not be diagnosed with AMI, it can be used for early exclusion of important AMI diagnostic indicators, such as Myo negative, basically exclude myocardial infarction, and can also be used for the diagnosis of re infarction. Combined with clinical, if Myo is re elevated, it should be considered for re infarction or infarct extension.

The immunofluorescence double antibody sandwich method was used to detect the content of Myo in whole blood, serum and plasma samples. When the test sample is added to the reagent kit plus the sample hole, if there is Myo in the sample, then the fluorescein particle coated with Myo antibody is bound to Myo to form a complex. The compound moves laterally along the test paper, and the Myo of the fluorescein particles is captured in the detection area, while the excess excess fluorescein particles are captured in the quality control area. When the reagent card was inserted into the Newcombe degree fluorescent immunoassay analyzer in Wuhan, the analyzer automatically scanned two ribbons and detected the fluorescence intensity of the compound emitted from the detection area and the quality control area. The content of the measured material was calculated by the ratio of two color band fluorescence intensity.

It is suitable for the fluorescent immunoassay quantitative analyzer produced by Newcombe bio Polytron Technologies Inc, Wuhan. Model: NCD-A.